Cytokine Growth Factor Rev 39:151158
Key Research Features Dual-mechanism research blend angiogenic + cytoskeletal pathways BPC-157: VEGF/VEGFR2-Akt-eNOS axis and NO system modulation TB-500: actin sequestration and G-actin/F-actin polymerization balance Precision co-lyophilized 1:1 ratio minimizes preparation variability 20mg total content suited for high-throughput and extended protocols 99% HPLC-verified purity per component Lyophilized powder format Suitable for in vitro and preclinical research Batch-tested for consistency Research-grade manufacturing standards Professionally labeled and documented Storage Recommendations To maintain product stability and research integrity, BPC-157 / TB-500 should be: Stored at 20C in a tightly sealed container Reconstituted with sterile bacteriostatic water, added slowly along the vial wall with gentle swirling avoid vigorous shaking Protected from light and moisture Kept sealed until use Handled according to standard laboratory procedures Not subjected to repeated freeze-thaw cycles Toxicology and Regulatory Information BPC-157 evaluated in preclinical toxicology research models BPC-157 listed by the U.S
[DOI] [PubMed] [Google Scholar] 163.Nwose E
Hexarelin: Mechanism and evidence base Hexarelin (examorelin, CAS 140703-51-1), a synthetic hexapeptide (CHNO, MW 887 g/mol), is the most potent GHS-R1a agonist in the GHRP class by comparative GH-stimulating assay, but is distinguished by a prominent cortisol and ACTH co-stimulation and a set of GHS-R1a-independent cardiac binding data that has generated a distinct line of cardioprotective research
Supports a calm, comfortable finish designed for consistent daily use
Each bottle contains 240 capsules a 4-month supply at the recommended serving
